Annual Net Income
$106.14 M
+$4.72 M+4.66%
31 December 2023
Summary:
Corcept Therapeutics Incorporated annual net profit is currently $106.14 million, with the most recent change of +$4.72 million (+4.66%) on 31 December 2023. During the last 3 years, it has fallen by -$6.37 million (-5.66%). CORT annual net income is now -17.80% below its all-time high of $129.12 million, reached on 31 December 2017.CORT Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
$47.21 M
+$11.72 M+33.04%
30 September 2024
Summary:
Corcept Therapeutics Incorporated quarterly net profit is currently $47.21 million, with the most recent change of +$11.72 million (+33.04%) on 30 September 2024. Over the past year, it has increased by +$15.86 million (+50.58%). CORT quarterly net income is now -51.99% below its all-time high of $98.33 million, reached on 31 December 2017.CORT Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
$141.82 M
+$15.84 M+12.57%
30 September 2024
Summary:
Corcept Therapeutics Incorporated TTM net profit is currently $141.82 million, with the most recent change of +$15.84 million (+12.57%) on 30 September 2024. Over the past year, it has increased by +$35.68 million (+33.61%). CORT TTM net income is now -6.53% below its all-time high of $151.73 million, reached on 30 September 2018.CORT TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CORT Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +50.6% | +33.6% |
| 3 y3 years | -5.7% | +47.3% | +26.1% |
| 5 y5 years | +12.7% | +60.7% | +50.6% |
CORT Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -5.7% | +4.7% | at high | +197.3% | at high | +55.2% |
| 5 y | 5 years | -5.7% | +12.7% | at high | +197.3% | at high | +55.2% |
| alltime | all time | -17.8% | +330.7% | -52.0% | +438.9% | -6.5% | +396.3% |
Corcept Therapeutics Incorporated Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $47.21 M(+33.0%) | $141.82 M(+12.6%) |
| June 2024 | - | $35.49 M(+27.8%) | $125.98 M(+6.7%) |
| Mar 2024 | - | $27.76 M(-11.5%) | $118.02 M(+11.2%) |
| Dec 2023 | $106.14 M(+4.7%) | $31.36 M(-0.1%) | $106.14 M(+16.1%) |
| Sept 2023 | - | $31.38 M(+14.0%) | $91.39 M(-3.4%) |
| June 2023 | - | $27.53 M(+73.4%) | $94.62 M(+0.1%) |
| Mar 2023 | - | $15.88 M(-4.3%) | $94.50 M(-6.8%) |
| Dec 2022 | $101.42 M(-9.9%) | $16.60 M(-52.0%) | $101.42 M(-13.2%) |
| Sept 2022 | - | $34.61 M(+26.3%) | $116.87 M(+3.7%) |
| June 2022 | - | $27.41 M(+20.2%) | $112.73 M(+0.8%) |
| Mar 2022 | - | $22.80 M(-28.9%) | $111.84 M(-0.6%) |
| Dec 2021 | $112.51 M(+6.1%) | $32.05 M(+5.2%) | $112.51 M(+5.7%) |
| Sept 2021 | - | $30.47 M(+14.9%) | $106.45 M(+9.1%) |
| June 2021 | - | $26.52 M(+13.0%) | $97.61 M(-1.8%) |
| Mar 2021 | - | $23.46 M(-9.7%) | $99.41 M(-6.2%) |
| Dec 2020 | $106.01 M(+12.6%) | $25.99 M(+20.2%) | $106.01 M(-3.1%) |
| Sept 2020 | - | $21.63 M(-23.7%) | $109.40 M(-4.1%) |
| June 2020 | - | $28.33 M(-5.8%) | $114.11 M(+7.7%) |
| Mar 2020 | - | $30.07 M(+2.3%) | $105.97 M(+12.5%) |
| Dec 2019 | $94.18 M(+24.9%) | $29.38 M(+11.5%) | $94.18 M(+8.5%) |
| Sept 2019 | - | $26.34 M(+30.5%) | $86.81 M(+11.0%) |
| June 2019 | - | $20.19 M(+10.5%) | $78.22 M(+2.6%) |
| Mar 2019 | - | $18.27 M(-17.0%) | $76.22 M(+1.1%) |
| Dec 2018 | $75.41 M(-41.6%) | $22.01 M(+24.0%) | $75.41 M(-50.3%) |
| Sept 2018 | - | $17.75 M(-2.5%) | $151.73 M(+2.7%) |
| June 2018 | - | $18.20 M(+4.2%) | $147.74 M(+3.9%) |
| Mar 2018 | - | $17.46 M(-82.2%) | $142.19 M(+10.1%) |
| Dec 2017 | $129.12 M(+1486.3%) | $98.33 M(+614.8%) | $129.12 M(+264.9%) |
| Sept 2017 | - | $13.76 M(+8.8%) | $35.39 M(+46.1%) |
| June 2017 | - | $12.65 M(+188.2%) | $24.22 M(+93.0%) |
| Mar 2017 | - | $4.39 M(-4.5%) | $12.55 M(+54.1%) |
| Dec 2016 | $8.14 M(-227.0%) | $4.60 M(+77.8%) | $8.14 M(+80.8%) |
| Sept 2016 | - | $2.58 M(+164.6%) | $4.50 M(+242.1%) |
| June 2016 | - | $977.00 K(-5242.1%) | $1.32 M(-182.4%) |
| Mar 2016 | - | -$19.00 K(-102.0%) | -$1.60 M(-75.1%) |
| Dec 2015 | -$6.41 M(-79.6%) | $959.00 K(-259.6%) | -$6.41 M(-43.1%) |
| Sept 2015 | - | -$601.00 K(-69.0%) | -$11.26 M(-32.4%) |
| June 2015 | - | -$1.94 M(-59.9%) | -$16.67 M(-25.2%) |
| Mar 2015 | - | -$4.83 M(+24.0%) | -$22.28 M(-29.0%) |
| Dec 2014 | -$31.38 M(-31.8%) | -$3.90 M(-35.1%) | -$31.38 M(-18.7%) |
| Sept 2014 | - | -$6.01 M(-20.5%) | -$38.61 M(-11.3%) |
| June 2014 | - | -$7.55 M(-45.8%) | -$43.51 M(-9.1%) |
| Mar 2014 | - | -$13.93 M(+25.2%) | -$47.86 M(+4.0%) |
| Dec 2013 | -$46.01 M | -$11.12 M(+2.0%) | -$46.01 M(0.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2013 | - | -$10.91 M(-8.3%) | -$46.01 M(+6.0%) |
| June 2013 | - | -$11.90 M(-1.5%) | -$43.40 M(+11.0%) |
| Mar 2013 | - | -$12.08 M(+8.6%) | -$39.10 M(+2.8%) |
| Dec 2012 | -$38.05 M(+17.6%) | -$11.12 M(+34.1%) | -$38.05 M(+3.2%) |
| Sept 2012 | - | -$8.29 M(+9.2%) | -$36.86 M(+5.3%) |
| June 2012 | - | -$7.60 M(-31.1%) | -$35.00 M(-3.5%) |
| Mar 2012 | - | -$11.03 M(+11.1%) | -$36.29 M(+12.2%) |
| Dec 2011 | -$32.35 M(+24.6%) | -$9.94 M(+54.4%) | -$32.35 M(+9.6%) |
| Sept 2011 | - | -$6.43 M(-27.6%) | -$29.51 M(-2.2%) |
| June 2011 | - | -$8.88 M(+25.1%) | -$30.18 M(+11.8%) |
| Mar 2011 | - | -$7.10 M(+0.1%) | -$26.99 M(+4.0%) |
| Dec 2010 | -$25.97 M(+28.8%) | -$7.09 M(-0.2%) | -$25.96 M(+8.0%) |
| Sept 2010 | - | -$7.10 M(+24.7%) | -$24.04 M(+11.3%) |
| June 2010 | - | -$5.70 M(-6.2%) | -$21.61 M(+3.9%) |
| Mar 2010 | - | -$6.07 M(+17.5%) | -$20.79 M(+3.1%) |
| Dec 2009 | -$20.17 M(+0.5%) | -$5.17 M(+10.8%) | -$20.17 M(-4.7%) |
| Sept 2009 | - | -$4.67 M(-4.3%) | -$21.17 M(-4.1%) |
| June 2009 | - | -$4.88 M(-10.5%) | -$22.06 M(+2.2%) |
| Mar 2009 | - | -$5.45 M(-11.7%) | -$21.58 M(+7.6%) |
| Dec 2008 | -$20.06 M(+73.3%) | -$6.17 M(+10.9%) | -$20.06 M(+10.9%) |
| Sept 2008 | - | -$5.57 M(+26.6%) | -$18.08 M(+13.4%) |
| June 2008 | - | -$4.40 M(+11.9%) | -$15.95 M(+23.0%) |
| Mar 2008 | - | -$3.93 M(-6.3%) | -$12.97 M(+12.1%) |
| Dec 2007 | -$11.57 M(-53.5%) | -$4.19 M(+22.3%) | -$11.57 M(+2.8%) |
| Sept 2007 | - | -$3.43 M(+141.9%) | -$11.26 M(-20.9%) |
| June 2007 | - | -$1.42 M(-44.1%) | -$14.23 M(-31.2%) |
| Mar 2007 | - | -$2.54 M(-34.6%) | -$20.68 M(-16.9%) |
| Dec 2006 | -$24.87 M(+23.8%) | -$3.88 M(-39.5%) | -$24.87 M(-5.2%) |
| Sept 2006 | - | -$6.40 M(-18.6%) | -$26.24 M(+4.7%) |
| June 2006 | - | -$7.86 M(+16.8%) | -$25.06 M(+17.6%) |
| Mar 2006 | - | -$6.73 M(+28.3%) | -$21.31 M(+6.1%) |
| Dec 2005 | -$20.09 M(+29.3%) | -$5.25 M(+0.5%) | -$20.09 M(-0.3%) |
| Sept 2005 | - | -$5.22 M(+27.0%) | -$20.16 M(+6.0%) |
| June 2005 | - | -$4.11 M(-25.4%) | -$19.02 M(+2.9%) |
| Mar 2005 | - | -$5.51 M(+3.8%) | -$18.50 M(+19.1%) |
| Dec 2004 | -$15.54 M(+58.3%) | -$5.31 M(+29.9%) | -$15.54 M(+27.2%) |
| Sept 2004 | - | -$4.09 M(+14.1%) | -$12.21 M(+19.1%) |
| June 2004 | - | -$3.58 M(+40.5%) | -$10.25 M(+7.3%) |
| Mar 2004 | - | -$2.55 M(+28.2%) | -$9.55 M(-2.7%) |
| Dec 2003 | -$9.81 M(-47.0%) | -$1.99 M(-6.6%) | -$9.81 M(+25.4%) |
| Sept 2003 | - | -$2.13 M(-26.1%) | -$7.82 M(+37.4%) |
| June 2003 | - | -$2.88 M(+2.5%) | -$5.69 M(+102.5%) |
| Mar 2003 | - | -$2.81 M | -$2.81 M |
| Dec 2002 | -$18.50 M(+148.2%) | - | - |
| Dec 2001 | -$7.45 M | - | - |
FAQ
- What is Corcept Therapeutics Incorporated annual net profit?
- What is the all time high annual net income for Corcept Therapeutics Incorporated?
- What is Corcept Therapeutics Incorporated quarterly net profit?
- What is the all time high quarterly net income for Corcept Therapeutics Incorporated?
- What is Corcept Therapeutics Incorporated quarterly net income year-on-year change?
- What is Corcept Therapeutics Incorporated TTM net profit?
- What is the all time high TTM net income for Corcept Therapeutics Incorporated?
- What is Corcept Therapeutics Incorporated TTM net income year-on-year change?
What is Corcept Therapeutics Incorporated annual net profit?
The current annual net income of CORT is $106.14 M
What is the all time high annual net income for Corcept Therapeutics Incorporated?
Corcept Therapeutics Incorporated all-time high annual net profit is $129.12 M
What is Corcept Therapeutics Incorporated quarterly net profit?
The current quarterly net income of CORT is $47.21 M
What is the all time high quarterly net income for Corcept Therapeutics Incorporated?
Corcept Therapeutics Incorporated all-time high quarterly net profit is $98.33 M
What is Corcept Therapeutics Incorporated quarterly net income year-on-year change?
Over the past year, CORT quarterly net profit has changed by +$15.86 M (+50.58%)
What is Corcept Therapeutics Incorporated TTM net profit?
The current TTM net income of CORT is $141.82 M
What is the all time high TTM net income for Corcept Therapeutics Incorporated?
Corcept Therapeutics Incorporated all-time high TTM net profit is $151.73 M
What is Corcept Therapeutics Incorporated TTM net income year-on-year change?
Over the past year, CORT TTM net profit has changed by +$35.68 M (+33.61%)